Astrazeneca reported $3.6B in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
AstraZeneca AZN:LN USD 3.6B 404M
Astrazeneca AZN:US USD 3.6B 404M
Bristol Myers Squibb BMY:US USD 5.32B 456M
Canopy Growth Corp WEED:CN CAD -95980000 11.78M
Catalent CTLT:US USD 161M 200M
Corcept Therapeutics CORT:US USD 32.13M 581K
Eli Lilly And LLY:US USD 2.31B 308.9M
Endo International Ordinary Shares ENDP:US USD 151.76M 22.28M
GlaxoSmithKline GSK:LN GBP 3.36B 916M
Horizon Pharma HZNP:US USD 287.24M 42.81M
Johnson & Johnson JNJ:US USD 7.34B 1.2B
Lannett LCI:US USD -10082000 6.25M
Novartis NOVN:VX USD 4.69B 34M
Pacira Pharmaceuticals PCRX:US USD 41.98M 7.94M
Perrigo Ordinary Shares PRGO:US USD 140.7M 54.6M
Pfizer PFE:US USD 10.52B 2.78B
Prestige Brands PBH:US USD 92.63M 2.77M
Roche Holding ROG:VX 13.44B 2.56B
Teva Pharmaceutical Industries TEVA:US USD 1.06B 31M
Valeant Pharmaceuticals VRX:CN USD 713M 80M
Zoetis ZTS:US USD 840M 14M